MicroMatrices is founded upon an extensive toxicological research experience base acquired at major international research centers of excellence in the USA , UK, and the Australia.
MicroMatrices, founded in 2011, is based in Dundee, Scotland, United Kingdom, a center for world class life science research and innovation.
We combine decades of academic and industrial toxicological experience in genomic and pathways analysis with expertise in pathology-guided molecular visualization/ localisation/quantification of tissue biomarkers.
MicroMatrices offers proprietary patent-protected technologies and regularly publishes original research.
Histology and Microphysiological systems (MPS)
In vitro 3D models are increasingly integral to drug discovery and drug development programs with many commercial safety…
Meet us in San Diego at SOT 2022
We look forward to re-connecting with clients/colleagues at the first on-site SOT in two years, held this year…
Transcriptomics with SpheroMatrices microTMA
The addition of a spatially defined overlay of transcriptomics to cytotoxicity/histological findings, or biomarker expression/localization image data, adds…
on an interactive, step by step basis. Collaborations can begin with pilot projects which can then be scaled up to larger research programs, according to your requirements.